Denali Advisors’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,300
| Closed | -$200K | – | 509 |
|
|
2023
Q3 | $200K | Sell |
14,300
-4,700
| -25% | -$65.8K | 0.07% | 226 |
|
|
2023
Q2 | $197K | Buy |
+19,000
| New | +$197K | 0.07% | 215 |
|
|
2022
Q2 | – | Sell |
-4,100
| Closed | -$36K | – | 420 |
|
|
2022
Q1 | $36K | Buy |
+4,100
| New | +$36K | 0.01% | 273 |
|